Home › Funds › CANADA LIFE ASSURANCE Co › GILD

CANADA LIFE ASSURANCE Co position in GILD

GILEAD SCIENCES INC · Health Care

CANADA LIFE ASSURANCE Co reported holding 1,591,387 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$236.9M, representing 0.39% of its reported portfolio and ranking #44 among its reported holdings. CANADA LIFE ASSURANCE Co has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.59M sh
Reported value held$236.87M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CANADA LIFE ASSURANCE Co's GILD position evolved

CANADA LIFE ASSURANCE Co first disclosed a stake in GILD in Q3 2023 at 1,817,248 shares (US$136.2M). The position peaked in Q3 2025 at 2,255,828 shares, worth US$254.0M. Across 13 filings, CANADA LIFE ASSURANCE Co increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,591,387 shares valued at US$236.9M — a reduction of -56,643 shares quarter over quarter.. Notable position changes include a 25% trim in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.82M $136.20M New
Q4 2023 1.79M $144.16M Reduce
Q1 2024 1.81M $132.62M Add
Q2 2024 2.13M $146.37M Add
Q3 2024 2.17M $182.09M Add
Q4 2024 2.10M $193.53M Reduce
Q1 2025 2.20M $246.40M Add
Q2 2025 2.23M $247.16M Add
Q3 2025 2.26M $254.01M Add
Q4 2025 1.68M $206.88M Reduce
Q1 2026 1.68M $234.24M Reduce
Q2 2026 1.65M $207.83M Reduce
Q3 2026 1.59M $236.87M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has CANADA LIFE ASSURANCE Co held GILD?

CANADA LIFE ASSURANCE Co has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CANADA LIFE ASSURANCE Co's current position in GILD?

As of Q3 2026, CANADA LIFE ASSURANCE Co holds 1.59M shares of GILD (GILEAD SCIENCES INC), valued at $236.87M, representing 0.39% of its reported portfolio and ranking #44.

Has CANADA LIFE ASSURANCE Co been buying or selling GILD?

In the latest 13F filing (Q3 2026), CANADA LIFE ASSURANCE Co reduced its position in GILD. The position peaked in Q3 2025 at 2.26M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.